108 related articles for article (PubMed ID: 3038264)
1. Localization of neurotensin receptors in the forebrain of the common marmoset and the effects of treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Waters CM; Hunt SP; Jenner P; Marsden CD
Brain Res; 1987 Jun; 412(2):244-53. PubMed ID: 3038264
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
Waters CM; Hunt SP; Jenner P; Marsden CD
Neuroscience; 1987 Dec; 23(3):1025-39. PubMed ID: 2893993
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
Quirion R; Welner S; Gauthier S; Bédard P
Synapse; 1987; 1(6):559-66. PubMed ID: 2843996
[TBL] [Abstract][Full Text] [Related]
4. Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study.
Szigethy E; Beaudet A
J Comp Neurol; 1989 Jan; 279(1):128-37. PubMed ID: 2563267
[TBL] [Abstract][Full Text] [Related]
5. Bilateral modulation of [3H]neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: evidence from a receptor autoradiographic study.
Cadet JL; Kujirai K; Przedborski S
Brain Res; 1991 Nov; 564(1):37-44. PubMed ID: 1663814
[TBL] [Abstract][Full Text] [Related]
6. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
Quirion R; Chiueh CC; Everist HD; Pert A
Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
8. The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Gibb WR; Terruli M; Lees AJ; Jenner P; Marsden CD
Mov Disord; 1989; 4(1):53-74. PubMed ID: 2494438
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicity.
Willoughby J; Glover V; Sandler M; Albanese A; Jenner P; Marsden CD
Neurosci Lett; 1988 Jul; 90(1-2):100-6. PubMed ID: 3137508
[TBL] [Abstract][Full Text] [Related]
10. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminals in the nigrostriatal and mesolimbic pathways in rat brain.
Schotte A; Leysen JE
J Chem Neuroanat; 1989; 2(5):253-7. PubMed ID: 2553068
[TBL] [Abstract][Full Text] [Related]
12. Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Perry TL; Yong VW; Hansen S; Jones K; Bergeron C; Foulks JG; Wright JM
J Neurol Sci; 1987 Nov; 81(2-3):321-31. PubMed ID: 3121800
[TBL] [Abstract][Full Text] [Related]
13. Morphological substrate for neurotensin-dopamine interactions in the rat midbrain tegmentum.
Beaudet A; Woulfe J
Ann N Y Acad Sci; 1992; 668():173-85. PubMed ID: 1361112
[No Abstract] [Full Text] [Related]
14. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
15. Pathology of MPTP in the marmoset.
Gibb WR; Lees AJ; Wells FR; Barnard RO; Jenner P; Marsden CD
Adv Neurol; 1987; 45():187-90. PubMed ID: 3103386
[No Abstract] [Full Text] [Related]
16. The effect of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on uridine uptake in the mouse brain.
Pakkenberg H; Pakkenberg B; Kjeldsen C
Brain Res; 1986 Jan; 362(1):192-4. PubMed ID: 3484652
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
Savasta M; Dubois A; Scatton B
Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry.
Schneider JS; Markham CH
Brain Res; 1986 May; 373(1-2):258-67. PubMed ID: 2872936
[TBL] [Abstract][Full Text] [Related]
19. Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the adrenal glands as well as the brain in the marmoset.
Fine A; Reynolds GP; Nakajima N; Jenner P; Marsden CD
Neurosci Lett; 1985 Jul; 58(1):123-6. PubMed ID: 3931004
[TBL] [Abstract][Full Text] [Related]
20. Neurotensin receptor localization by light microscopic autoradiography in rat brain.
Young WS; Kuhar MJ
Brain Res; 1981 Feb; 206(2):273-85. PubMed ID: 6260280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
